We are live on ! Find out more
CVSC

C.V. Starr & Co Portfolio holdings

AUM $187M
1-Year Est. Return 26.03%
This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
+26.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$187M
AUM Growth
-$4.47M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 99.16%
2 Healthcare 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$147B
$92.6M 49.45%
251,400
IDEV icon
2
iShares Core MSCI International Developed Markets ETF
IDEV
$32.5B
$33.7M 18%
378,787
IJR icon
3
iShares Core S&P Small-Cap ETF
IJR
$107B
$29.7M 15.87%
200,458
IVOO icon
4
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.8B
$29.7M 15.83%
227,427
CELU icon
5
Celularity
CELU
$40.8M
$1.58M 0.84%
764,069

Similar funds

C.V. Starr & Co's Q2 2026 Portfolio in Review

As of Q2 2026, C.V. Starr & Co held 5 positions worth $187M, down 2.3% from $192M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 0%. C.V. Starr & Co opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 99% of assets, down from 99% a quarter earlier, followed by Healthcare.

  • C.V. Starr & Co's ten largest holdings make up 100% of its $187M portfolio in Q2 2026.
  • C.V. Starr & Co opened 0 new positions and closed 0 in Q2 2026.
  • C.V. Starr & Co's portfolio value fell 2.3% quarter-over-quarter to $187M.

Based on C.V. Starr & Co's 13F filing for Q2 2026, filed 11 Aug 2026.